IDH2 and cholangiocarcinoma: IDH1 and IDH2 mutations have been found in other non-CNS neoplasms, including cholangiocarcinoma, acute myeloid leukemia, chondrosarcoma, and angioimmunoblastic T-cell lymphoma, but the pathogenesis in these entities remains unclear [6-8].